Copyright Reports & Markets. All rights reserved.

Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Acute Myeloid Leukemia (AML) Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Chemotherapy
    • 1.4.3 Radiation therapy
    • 1.4.4 Stem Cell Transplant
    • 1.4.5 Targeted Therapy
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Retails Drug Stores
    • 1.5.4 Ambulatory Care Centers
    • 1.5.5 Oncology Centers
    • 1.5.6 Clinics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Acute Myeloid Leukemia (AML) Therapeutics Growth Trends by Regions
    • 2.2.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Acute Myeloid Leukemia (AML) Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Acute Myeloid Leukemia (AML) Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Acute Myeloid Leukemia (AML) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Market Size
    • 3.1.1 Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio
    • 3.2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia (AML) Therapeutics Revenue in 2019
  • 3.3 Acute Myeloid Leukemia (AML) Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Acute Myeloid Leukemia (AML) Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 6.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 7.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 8.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in China (2019-2020)
  • 8.3 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 9.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 10.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 11.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in India (2019-2020)
  • 11.3 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2015-2020)
  • 12.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bristol-Myers Squibb
    • 13.1.1 Bristol-Myers Squibb Company Details
    • 13.1.2 Bristol-Myers Squibb Business Overview
    • 13.1.3 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Introduction
    • 13.1.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2015-2020))
    • 13.1.5 Bristol-Myers Squibb Recent Development
  • 13.2 Novartis
    • 13.2.1 Novartis Company Details
    • 13.2.2 Novartis Business Overview
    • 13.2.3 Novartis Acute Myeloid Leukemia (AML) Therapeutics Introduction
    • 13.2.4 Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2015-2020)
    • 13.2.5 Novartis Recent Development
  • 13.3 Roche
    • 13.3.1 Roche Company Details
    • 13.3.2 Roche Business Overview
    • 13.3.3 Roche Acute Myeloid Leukemia (AML) Therapeutics Introduction
    • 13.3.4 Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2015-2020)
    • 13.3.5 Roche Recent Development
  • 13.4 Genmab
    • 13.4.1 Genmab Company Details
    • 13.4.2 Genmab Business Overview
    • 13.4.3 Genmab Acute Myeloid Leukemia (AML) Therapeutics Introduction
    • 13.4.4 Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2015-2020)
    • 13.4.5 Genmab Recent Development
  • 13.5 GlaxoSmithKline Pharmaceuticals
    • 13.5.1 GlaxoSmithKline Pharmaceuticals Company Details
    • 13.5.2 GlaxoSmithKline Pharmaceuticals Business Overview
    • 13.5.3 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Introduction
    • 13.5.4 GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2015-2020)
    • 13.5.5 GlaxoSmithKline Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Acute Myeloid Leukemia (AML) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia (AML) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Bristol-Myers Squibb
    Novartis
    Roche
    Genmab
    GlaxoSmithKline Pharmaceuticals
    ...

    Market segment by Type, the product can be split into
    Chemotherapy
    Radiation therapy
    Stem Cell Transplant
    Targeted Therapy
    Others
    Market segment by Application, split into
    Hospital
    Retails Drug Stores
    Ambulatory Care Centers
    Oncology Centers
    Clinics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now